These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 15196549

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prognostic significance of reversion-inducing cysteine-rich protein with Kazal motifs expression in resected pathologic stage IIIA N2 non-small-cell lung cancer.
    Takenaka K, Ishikawa S, Yanagihara K, Miyahara R, Hasegawa S, Otake Y, Morioka Y, Takahashi C, Noda M, Ito H, Wada H, Tanaka F.
    Ann Surg Oncol; 2005 Oct; 12(10):817-24. PubMed ID: 16132376
    [Abstract] [Full Text] [Related]

  • 3. Low expression of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) indicates a shorter survival after resection in patients with adenocarcinoma of the lung.
    Takemoto N, Tada M, Hida Y, Asano T, Cheng S, Kuramae T, Hamada J, Miyamoto M, Kondo S, Moriuchi T.
    Lung Cancer; 2007 Dec; 58(3):376-83. PubMed ID: 17714826
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
    O'Byrne KJ, Koukourakis MI, Giatromanolaki A, Cox G, Turley H, Steward WP, Gatter K, Harris AL.
    Br J Cancer; 2000 Apr; 82(8):1427-32. PubMed ID: 10780522
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer.
    Takeuchi T, Hisanaga M, Nagao M, Ikeda N, Fujii H, Koyama F, Mukogawa T, Matsumoto H, Kondo S, Takahashi C, Noda M, Nakajima Y.
    Clin Cancer Res; 2004 Aug 15; 10(16):5572-9. PubMed ID: 15328199
    [Abstract] [Full Text] [Related]

  • 9. Expression of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) as a prognostic indicator in gastric cancer.
    Song SY, Son HJ, Nam E, Rhee JC, Park C.
    Eur J Cancer; 2006 Jan 15; 42(1):101-8. PubMed ID: 16324834
    [Abstract] [Full Text] [Related]

  • 10. Vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 expression in non-small cell lung cancer patients: relation to prognosis.
    Bonnesen B, Pappot H, Holmstav J, Skov BG.
    Lung Cancer; 2009 Dec 15; 66(3):314-8. PubMed ID: 19324448
    [Abstract] [Full Text] [Related]

  • 11. Maspin expression and its clinical significance in non-small cell lung cancer.
    Nakagawa M, Katakura H, Adachi M, Takenaka K, Yanagihara K, Otake Y, Wada H, Tanaka F.
    Ann Surg Oncol; 2006 Nov 15; 13(11):1517-23. PubMed ID: 17009165
    [Abstract] [Full Text] [Related]

  • 12. Expression of tissue inhibitor of metalloproteinase-3 (TIMP-3) and its prognostic significance in resected non-small cell lung cancer.
    Mino N, Takenaka K, Sonobe M, Miyahara R, Yanagihara K, Otake Y, Wada H, Tanaka F.
    J Surg Oncol; 2007 Mar 01; 95(3):250-7. PubMed ID: 17323339
    [Abstract] [Full Text] [Related]

  • 13. Flt-4-positive endothelial cell density and its clinical significance in non-small cell lung cancer.
    Chen F, Takenaka K, Ogawa E, Yanagihara K, Otake Y, Wada H, Tanaka F.
    Clin Cancer Res; 2004 Dec 15; 10(24):8548-53. PubMed ID: 15623638
    [Abstract] [Full Text] [Related]

  • 14. Expression of matrix metalloproteinase regulator, RECK, and its clinical significance in osteosarcoma.
    Xu J, Wu S, Shi X.
    J Orthop Res; 2010 Dec 15; 28(12):1621-5. PubMed ID: 20973064
    [Abstract] [Full Text] [Related]

  • 15. [Vascular endothelial growth factor expression and microvessel density in stage I-II non-small cell lung cancer and their prognostic significances].
    Zhu ZH, Rong TH, Zeng CG, Wu QL, Ma Y, Huang XP, Li BJ, Zhang PY, Zhao JM, Hu W, Zhang SY, Yu H, Ma GW, Zhang LJ, Wen ZS, Fu JH, Long H.
    Ai Zheng; 2005 Jul 15; 24(7):865-9. PubMed ID: 16004817
    [Abstract] [Full Text] [Related]

  • 16. Expression of X-linked inhibitor of apoptosis as a novel prognostic marker in radically resected non-small cell lung cancer patients.
    Ferreira CG, van der Valk P, Span SW, Ludwig I, Smit EF, Kruyt FA, Pinedo HM, van Tinteren H, Giaccone G.
    Clin Cancer Res; 2001 Aug 15; 7(8):2468-74. PubMed ID: 11489828
    [Abstract] [Full Text] [Related]

  • 17. RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis.
    Masui T, Doi R, Koshiba T, Fujimoto K, Tsuji S, Nakajima S, Koizumi M, Toyoda E, Tulachan S, Ito D, Kami K, Mori T, Wada M, Noda M, Imamura M.
    Clin Cancer Res; 2003 May 15; 9(5):1779-84. PubMed ID: 12738734
    [Abstract] [Full Text] [Related]

  • 18. [Predicting efficacy of neoadjuvant cheomotherapy on resectable stage IIIA non-small cell lung cancer by multi-gene expressions].
    Cheng C, Wu YL, Gu LJ, Chen G, Weng YM, Feng WN, Zhong WZ.
    Ai Zheng; 2005 Jul 15; 24(7):846-9. PubMed ID: 16004813
    [Abstract] [Full Text] [Related]

  • 19. Matrix metalloproteinase-9 activity is associated with poor prognosis in T3-T4 node-negative colorectal cancer.
    Cho YB, Lee WY, Song SY, Shin HJ, Yun SH, Chun HK.
    Hum Pathol; 2007 Nov 15; 38(11):1603-10. PubMed ID: 17669467
    [Abstract] [Full Text] [Related]

  • 20. Matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs: a prognostic marker for good clinical outcome in human breast carcinoma.
    Span PN, Sweep CG, Manders P, Beex LV, Leppert D, Lindberg RL.
    Cancer; 2003 Jun 01; 97(11):2710-5. PubMed ID: 12767082
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.